Envestnet Asset Management
CODX

Envestnet Asset Management’s Co-Diagnostics CODX Stock Holding History

Envestnet Asset Management’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,028
Closed -$10.6K – 4496
2025
Q3 		$10.6K Buy
1,028
+478
+87% +$4.45K ﹤0.01% 4498
2025
Q2 		$4.62K Buy
550
+138
+33% +$1.29K ﹤0.01% 4423
2025
Q1 		$3.83K Buy
+412
New +$7.87K ﹤0.01% 4338
2024
Q3 		– Sell
-629
Closed -$23.6K – 4236
2024
Q2 		$23.6K Buy
629
+30
+5% +$1.09K ﹤0.01% 4138
2024
Q1 		$20.1K Sell
599
-207
-26% -$7.5K ﹤0.01% 4139
2023
Q4 		$32.1K Sell
806
-3
-0.4% -$106 ﹤0.01% 4006
2023
Q3 		$25.7K Buy
+809
New +$30.6K ﹤0.01% 3967

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Envestnet Asset Management's CODX Position: Q4 2025 in Review

Envestnet Asset Management sold out of Co-Diagnostics (CODX) in Q4 2025, closing a stake of 1,028 shares — an estimated $10.6K sold.

Envestnet Asset Management first reported a position in CODX in Q3 2023 and held it in 7 quarters. The position peaked at $32.1K in Q4 2023. 30 funds tracked by Wall St. Rank hold CODX as of Q4 2025.

  • Envestnet Asset Management reported no remaining Co-Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 1,028 Co-Diagnostics shares in Q4 2025, an estimated $10.6K.
  • Envestnet Asset Management first reported a position in Co-Diagnostics in Q3 2023 and held it in 7 quarters.
  • Envestnet Asset Management's Co-Diagnostics position peaked at $32.1K in Q4 2023.
  • 30 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2025.

Based on Envestnet Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.